Post by
westcoast1000 on Dec 08, 2022 3:22pm
Positive results once again
ONCY and pela continue to produce positive results.
Hence, there is nothing in the way now, and no reason to doubt we will be hearing positive news on Bracelet in about three months or so.
What hurts many investors here is the disconnect with the share price.
I do not pay any real attention to the s/p. With other companies our results would matter a lot to the market, but because our price is already so disproportionately low, investors are staying out due to what they see as ongoing uncertainty.
Someone had a good comment on stocktwits. It is almost as if this company is going for a slam dunk on a registration trial before applying. To me, that makes sense. This is a one molecule company. pela is its only product. They are nurturing it through the approval process. That is why they have waited 5 years on the fast track designation for mBC.
But we have basically put every brick in place in the wall.
Now we wait for big pharma to buy what we have to offer.
Comment by
westcoast1000 on Dec 08, 2022 3:29pm
I guess it should be: ."...a one virus company." That is all we have. One wild-type virus that we have patented, and the intellectual property that it entails.
Comment by
westcoast1000 on Dec 08, 2022 3:31pm
...just to add: This happens to be a wild type virus that kills cancer, and inflames the human immune system because we have all had it, but does not hurt humans.
Comment by
fox7mf on Dec 08, 2022 4:42pm
Great post Westcoast. Do you put any weight into the theory floating around concerning a lack of a NR concerning Aware-1 stemming from a blackout on news due to ongoing negotiations with Roche?